Treatment with calcitonin
Falch, J.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 99(22): 1007-1008
1979
ISSN/ISBN: 0029-2001 PMID: 483291 Document Number: 143941
Document emailed within 1 workday
Related Documents
Ziegler, R.; Raue, F. 1984: Variations of plasma calcitonin levels measured by radioimmunoassay systems for human calcitonin Biomedicine and PharmacoTherapy 38(5): 245-251Yiin, K.T.; Chiang, C.D.; Chen, C.F.; Wang, S.J.; Lin, W.H.; Guu, C.J.; Lee, H.K.; Jih, K.S.; Lin, T.M.; Huang, W.L. 1987: The serum levels of human calcitonin (hCT) and salmon calcitonin (sCT) in lung cancer patients Zhonghua Yi Xue Za Zhi 40(6): 517-522
Dopplet, S.H.; Talmage, R.V. 1976: Calcitonin and the bone fluid compartment: effect of calcitonin and/or parathyroid hormone on plasma radiocalcium changes Clinical Orthopaedics and Related Research 118: 242-250
Suva, L.J.; Flannery, M.S.; Caulfield, M.P.; Findlay, D.M.; Jüppner, H.; Goldring, S.R.; Rosenblatt, M.; Chorev, M. 1997: Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor Journal of Pharmacology and Experimental Therapeutics 283(2): 876-884
Saller, B.; Goerges, R.; Reinhardt, W.; Haupt, K.; Janssen, O.E.; Mann, K. 2002: Sensitive Calcitonin Measurement by Two-site Immunometric Assays: Implications for Calcitonin Screening in Nodular Thyroid Disease Clinical Laboratory 48(3-4): 191-200
Galán Galán, F.; Garrido Peralta, M. 1982: Calcitonin as a tumor marker. II. Calcitonin in non-thyroid tumors Revista Clinica Espanola 165(2): 73-76
Lamari, Y.; Tahri, E.H.; Collignon, H.; Garel, J.M. 1994: Steroid hormones and retinoic acid interact in the regulation of calcitonin and calcitonin gene-related peptide secretion and messenger ribonucleic acid levels in CA-77 C cells Cellular and Molecular Biology 40(4): 541-550
Campailla, E. 1977: Treatment of bone metastases by calcitonin La Nouvelle Presse Medicale 6(33): 2994
Socha, J.; Brzozowska-Wolnik, D.; Ignyś, I.; Stańska, M. 1982: Treatment of osteogenesis imperfecta with calcitonin Pediatria Polska 57(9): 735-737
Capone, M.; Castagnoli, M.; Zorzin, L. 1980: Calcitonin in the treatment of osteoporosis in rheumatic disorders La Clinica Terapeutica 95(5): 503-522
Serdengeçti, S.; Serdengeçti, K.; Derman, U.; Berkarda, B. 1986: Salmon calcitonin in the treatment of bone metastases International Journal of Clinical Pharmacology Research 6(2): 151-155
Szücs, J.; Steczek, K. 1978: Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis Orvosi Hetilap 119(20): 1220-1224
Jaeger, H.; Maier, C.; Wawersik, J. 1988: Postoperative treatment of phantom pain and causalgias with calcitonin Der Anaesthesist 37(2): 71-76
1998: Why use calcitonin? New indication: no proven utility in the treatment of osteoporosis Prescrire International 7(33): 7-9
Staehelin, A. 1977: Treatment possibilities of arterial circulatory disorders using calcitonin Schweizerische Medizinische Wochenschrift 107(49): 1865-1867
Manderlier, T.; Fuss, M.; Brauman, J.; Orloff, S.; Bergans, A.; Corvilain, J. 1976: Treatment of Paget's disease of bone with salmon calcitonin Acta Clinica Belgica 31(6): 329-338
Bisson, R.; Morandi, A.; Vecchini, L. 1982: Synthetic salmon calcitonin. Treatment of choice in Sudeck's disease Minerva Medica 73(17): 1065-1069
Renier, J.C.; Boasson, M.; Jallet, P.; Bernat, M. 1973: Short term treatment of Paget's disease with porcine calcitonin Revue du Rhumatisme et des Maladies Osteo-Articulaires 40(10): 557-563
1975: Calcitonin : opening of a new epoch in the treatment of bone and joint diseases Minerva Medica 66(68 Suppl): 10-12
Kuntz, D.; Marie, P.; Berhel, M.; Caulin, F. 1986: Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin International Journal of Clinical Pharmacology Research 6(2): 157-162